← Leaderboards
Jana Portnow
University Of Southern California
$358,122
Attributed
$358,122
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $147.8K · FY2006–09$200K$150K$100K$50K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$358,122 · 9
By mechanism
M01$358,122 · 9
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Eric Peter Wilkinson$1,498,283
- David K Ann$16,827,823
- Yali Dou$14,878,089
- Jeffrey Y Wong$938,530
- Bodour Salhia$4,072,298
Others in their field
Top investigators on “Institution”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,187,810,557
- Leonard Freedman · Leidos Biomedical Research, Inc.$835,530,754
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$566,554,288
- Bambra Strokes · Ppd Development Lp$526,656,217
Research focus
InstitutionFundingResourcesComputer Retrieval Of Information On Scientific Projects DatabaseGrantResearch PersonnelTemozolomideSourceUnited States National Institutes Of HealthBrain NeoplasmsPharmaceutical PreparationsDrug KineticsGliomaMetastatic Malignant Neoplasm To BrainMetastatic/RecurrentClinical ResearchEnzymesChemotherapyMicrodialysisDose-LimitingCerebrospinal FluidDoseBortezomibIn Complete Remission
Grant awards (9)
A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID$77,684
M01 · FY2009 · RR · contact PI
A PHARMACOKINETIC AND PHARMACOGENOMIC STUDY OF PATIENTS WITH HIGH-GRADE$8,115
M01 · FY2009 · RR · contact PI
PILOT FEASIBILITY DOSE ESCALATION STUDY USING INTRACEREBRAL MICRODIALYSIS$2,320
M01 · FY2009 · RR · contact PI
A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID$108,156
M01 · FY2008 · RR · contact PI
A PILOT FEASIBILITY STUDY OF INTRACEREBRAL MICRODIALYSIS TO DETERMINE THE NEURO$21,631
M01 · FY2008 · RR · contact PI
A PHARMACOKINETIC AND PHARMACOGENOMIC STUDY OF PATIENTS WITH HIGH-GRADE$18,026
M01 · FY2008 · RR · contact PI
A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID$66,869
M01 · FY2007 · RR · contact PI
A PILOT FEASIBILITY STUDY OF INTRACEREBRAL MICRODIALYSIS TO DETERMINE THE NEURO$28,105
M01 · FY2007 · RR · contact PI
A PHASE I STUDY OF BORTEZOMIB AND TEMOZOLOMIDE IN PATIENTS WITH REFRACTORY SOLID$27,216
M01 · FY2006 · RR · contact PI